Kayne Anderson Rudnick Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Kayne Anderson Rudnick Investment Management's BIIB Position: Q2 2026 in Review
Kayne Anderson Rudnick Investment Management opened a new position in Biogen (BIIB) in Q2 2026: 20 shares worth $4.38K. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings. This is a return to the name: Kayne Anderson Rudnick Investment Management previously reported a position in BIIB as recently as Q2 2025.
Kayne Anderson Rudnick Investment Management first reported a position in BIIB in Q4 2019 and has held it in 18 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Kayne Anderson Rudnick Investment Management held 20 shares of Biogen worth $4.38K as of Q2 2026.
- Biogen was a new Kayne Anderson Rudnick Investment Management position in Q2 2026.
- Biogen made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #799 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in Biogen in Q4 2019 and has held it in 18 quarters since.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.